Clinical Cardiology Alert – November 1, 2015
November 1, 2015
View Issues
-
Reduced Leaflet Motion in Bioprosthetic Valves
ABSTRACT & COMMENTARY: It's in a significant proportion of surgical and transcatheter bioprosthetic aortic valves by volume-rendered CT scans.
-
Beta-blocker Dose More Important Than Heart Rate in Systolic Heart Failure
In chronic heart failure with reduced ejection fraction, titrating beta-blocker doses may confer a greater benefit than reducing heart rate.
-
Slow Down, Save Lives? Rate Control in Atrial Fibrillation
Atrial fibrillation patients receiving beta-blockers or calcium channel blockers had lower risk of mortality compared to those not taking rate-control drugs, with the lowest mortality rate in the beta-blocker group, while digoxin use was associated with a higher risk of mortality.
-
Finally, a Positive Outcomes Study for Platelet Function Testing
Platelet function testing-defined clopidogrel nonresponsiveness can be overcome by prasugrel treatment, and that this is a modifiable risk factor whose treatment can improve outcomes.
-
Blood Pressure Targets in Flux Again
Trial could be a game changer if the results are robust.